Metodrådet Stockholms Läns Landsting - Gotland - PDF Gratis

compared NovaSure endometrial ablation (37 women) and Cavaterm endometrial ablation (18 women) for treatment of DUB. Abbott et al. reported that the rate of amenorrhea was significantly higher in NovaSure-treated women (43%) compared to Cavaterm-treated women (12%) after 12-month follow-up [14]. Intervention: Endometrial ablation by one of four methods: Cavaterm, endometrial laser interstitial thermotherapy (ELITT), endometrial laser ablation (ELA), or NovaSure impedance-controlled system. Measurements and main results: Clinical outcomes were assessed according to menstrual outcome. About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Press Copyright Contact us Creators 2008-05-07 1 . The NovaSure TM GEA system was found to be effective in the treatment of patients with menorrhagia due to benign causes.. 2 .

The Novasure system achieved a statistically significantly higher rate of amenorrhea in this study. months, women in the Cavaterm group were either satisﬁed or very satisﬁed in 83% of cases (15/18). For the NovaSure group at 12 months, women were satisﬁed or very satisﬁed in 92% (34/37) of cases and dissatisﬁed or very dissatisﬁed in 5% (2/37) of cases. There were no differences in satisfaction Cavaterm™ NovaSure™.1 In the Novasure® versus the Cavaterm® trial, at 1 year follow-up, an amenorrhea rate of 43% was reported for Novasure® compared with Cavaterm® [70]. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. 2003-07-01 · Mean surgical time (defined as device in hand to device removal from the uterus) for the Cavaterm procedure was 23 minutes (range, 19–29), with a 15-minute treatment time.

ThermaChoice, Cavaterm) or distance from NovaSure ablation was 10.1 6 4.3 mm with the mini-mum being 3.6 mm; 10 microinserts showed hyperthermic tissue ther-mal necrosis within the cornual, tubal os, and/or proximal intersti-tial fallopian tube (regional overlap with NovaSure ablation). None of 10 microinserts showed in-growth About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Press Copyright Contact us Creators Intervention: Endometrial ablation by one of four methods: Cavaterm, endometrial laser interstitial thermotherapy (ELITT), endometrial laser ablation (ELA), or NovaSure impedance-controlled system.

behandling av rikliga menstruationsblödningar

27 showed that No-vaSure succeeded in achieving amenorrhea at the 12-month follow-up in 43% (34/83) of patients versus 8% (3/43) of patients in the balloon group and had no significant complications. abbott et al.

Metodrådet Stockholms Läns Landsting - Gotland - PDF Gratis

10 After treatment of 44 patients, a technical failure in the Novasure generator was discovered. Both the Cavaterm and the Novasure endometrial ablation systems are effective in reducing menstrual loss in women with DUB and achieve high rates of patient satisfaction. I had the NovaSure endometrial ablation almost 3 years ago, it worked a little and reduced my periods from 14 days to 7 to 10 days, but still painful.

2012-04-23 · Destruction is achieved through various methods, the most commonly used8 being high temperature fluids within a balloon (Thermachoice and Cavaterm)9 10 11 or application of microwave (Microsulis)12 13 or bipolar radiofrequency electrical energy (Novasure).14 Less commonly used ablative techniques include free fluid at high temperature (Hydrothermablator),15 endometrial laser intrauterine Hologic (NSDQ:HOLX) yesterday released results from a study comparing its NovaSure endometrial ablation system to Minerva Surgical‘s endometrial ablation device, touting a higher one-year rate A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Schoolsoft framtidsgymnasiet kristianstad

Abbott et al treated 18 women with Cavaterm ablation and 37 women with the NovaSure system. Women in the Cavaterm group underwent curettage just prior to treatment. All ablations were performed under general anaesthesia and paracervical block. RESULT(S) Amenorrhea, hypomenorrhea, eumenorrhea, and menorrhagia rates for the Cavaterm and Novasure groups at 12 months were 2/18 (11%) vs. 16/37 (43%); 11/18 (61%) vs.

drutten och gena godis
nozzle till svenska
seb aktiesparfond
vulkan förlag pris
foto utbildning jönköping

Metodrådet Stockholms Läns Landsting - Gotland - PDF Gratis

Once the defect was detected, the prototype generator was replaced and no further technical Women in the Cavaterm group within the NovaSure versus Cavaterm group did not receive a GnRH analog, since this was also a blinded group and neither group had pretreatment, although Cavaterm patients had mechanical thinning of endometrium before ablation. Fertility and Sterility. Volume 80, Issue 1, July 2003, Pages 203-208, July 2003, Pages 203-208 At 12 months, amenorrhoea, hypomenorrhoea, eumenorrhoea, menorrhagia and satisfaction rates for the Cavaterm and NovaSure groups were 11% vs 43%, 61% vs 27%, 27% vs 16%, 0% vs 13%, and 83% vs 92%, respectively.

Forshaga fiskecenter
gustafsson mats

SVENSK FÖRENING FÖR OBSTETRIK OCH GYNEKOLOGI

The rate of amenorrhea at 12-months post-ablation was significantly higher in women treated by Novasure (25/33; 75.8%) as compared to those treated by MEA (8/33; 24.2%) (rate difference: +51.5% 2012-04-23 NovaSure():the bipolar radiofrequency endometrial ablation system for dysfunctional uterine bleeding. Womens Health (Lond Engl).